Last reviewed · How we verify

NCT07454200

Feasibility, Acceptability, and Effectiveness of a Hatha Yoga-in Patients Hospitalized for Schizophrenia

Not yet recruiting NA Last updated 6 March 2026
What this trial tests

NA trial testing Intervention Arm: Hatha Yoga in SCHIZOPHRENIA 1 (Disorder) in 36 participants. Not yet recruiting.

Timeline
1 April 2026
Primary endpoint
30 November 2026
1 December 2027

Quick facts

Lead sponsorThe Hashemite University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment36
Start date1 April 2026
Primary completion30 November 2026
Estimated completion1 December 2027

Drugs / interventions tested

Conditions studied

Sponsor

The Hashemite University

Who can join

Adults 18 to 64, any sex, with SCHIZOPHRENIA 1 (Disorder) or Hospitalized Adult Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current study aims to examine the feasibility, acceptability, and preliminary effectiveness of a Hatha yoga-based group intervention on reminiscence functions and mindfulness in a sample of patients hospitalized for schizophrenia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for SCHIZOPHRENIA 1 (Disorder)

Currently open trials in the same condition.

Other The Hashemite University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07454200.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing